domingo, 24 de mayo de 2020

J&J should make bedaquiline affordable for people with TB - STAT

J&J should make bedaquiline affordable for people with TB - STAT

First Opinion

If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable

By SASHA CUTTLER AND MARY MAGEE AND GUY VANDENBERG


ADOBE
Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit.

No hay comentarios: